140 related articles for article (PubMed ID: 11878807)
21. A continuous fluorimetric assay for tail-specific protease.
Beebe KD; Pei D
Anal Biochem; 1998 Oct; 263(1):51-6. PubMed ID: 9750142
[TBL] [Abstract][Full Text] [Related]
22. Relaxed specificity of matrix metalloproteinases (MMPS) and TIMP insensitivity of tumor necrosis factor-alpha (TNF-alpha) production suggest the major TNF-alpha converting enzyme is not an MMP.
Black RA; Durie FH; Otten-Evans C; Miller R; Slack JL; Lynch DH; Castner B; Mohler KM; Gerhart M; Johnson RS; Itoh Y; Okada Y; Nagase H
Biochem Biophys Res Commun; 1996 Aug; 225(2):400-5. PubMed ID: 8753775
[TBL] [Abstract][Full Text] [Related]
23. Synthesis and characterization of novel fluorogenic substrates of coagulation factor XIII-A.
Hardes K; Zouhir Hammamy M; Steinmetzer T
Anal Biochem; 2013 Nov; 442(2):223-30. PubMed ID: 23933241
[TBL] [Abstract][Full Text] [Related]
24. Substrate specificity and inducibility of TACE (tumour necrosis factor alpha-converting enzyme) revisited: the Ala-Val preference, and induced intrinsic activity.
Black RA; Doedens JR; Mahimkar R; Johnson R; Guo L; Wallace A; Virca D; Eisenman J; Slack J; Castner B; Sunnarborg SW; Lee DC; Cowling R; Jin G; Charrier K; Peschon JJ; Paxton R
Biochem Soc Symp; 2003; (70):39-52. PubMed ID: 14587281
[TBL] [Abstract][Full Text] [Related]
25. Cleavage specificity of human rhinovirus-2 2A protease for peptide substrates.
Wang QM; Sommergruber W; Johnson RB
Biochem Biophys Res Commun; 1997 Jun; 235(3):562-6. PubMed ID: 9207196
[TBL] [Abstract][Full Text] [Related]
26. Application of peptides containing the cleavage sequence of pro-TNFalpha in assessing TACE activity of whole cells.
Becker BF; Gilles S; Sommerhoff CP; Zahler S
Biol Chem; 2002 Nov; 383(11):1821-6. PubMed ID: 12530549
[TBL] [Abstract][Full Text] [Related]
27. New continuous and specific fluorometric assays for Pseudomonas aeruginosa elastase and LasA protease.
Elston C; Wallach J; Saulnier J
Anal Biochem; 2007 Sep; 368(1):87-94. PubMed ID: 17553454
[TBL] [Abstract][Full Text] [Related]
28. Development of an internally quenched fluorescent substrate for Escherichia coli leader peptidase.
Zhong W; Benkovic SJ
Anal Biochem; 1998 Jan; 255(1):66-73. PubMed ID: 9448843
[TBL] [Abstract][Full Text] [Related]
29. Non-hydroxamate 5-phenylpyrimidine-2,4,6-trione derivatives as selective inhibitors of tumor necrosis factor-alpha converting enzyme.
Duan JJ; Lu Z; Wasserman ZR; Liu RQ; Covington MB; Decicco CP
Bioorg Med Chem Lett; 2005 Jun; 15(12):2970-3. PubMed ID: 15908214
[TBL] [Abstract][Full Text] [Related]
30. A continuous fluorimetric assay for aminopeptidase P detailed analysis of product inhibition.
Stöckel-Maschek A; Stiebitz B; Koelsch R; Neubert K
Anal Biochem; 2003 Nov; 322(1):60-7. PubMed ID: 14705781
[TBL] [Abstract][Full Text] [Related]
31. Partial purification and characterization of a tumor necrosis factor-alpha converting activity.
Robache-Gallea S; Bruneau JM; Robbe H; Morand V; Capdevila C; Bhatnagar N; Chouaib S; Roman-Roman S
Eur J Immunol; 1997 May; 27(5):1275-82. PubMed ID: 9174621
[TBL] [Abstract][Full Text] [Related]
32. Structure and functions of tumor necrosis factor-alpha converting enzyme.
Mezyk R; Bzowska M; Bereta J
Acta Biochim Pol; 2003; 50(3):625-45. PubMed ID: 14515145
[TBL] [Abstract][Full Text] [Related]
33. Design, synthesis, and evaluation of benzothiadiazepine hydroxamates as selective tumor necrosis factor-alpha converting enzyme inhibitors.
Cherney RJ; Duan JJ; Voss ME; Chen L; Wang L; Meyer DT; Wasserman ZR; Hardman KD; Liu RQ; Covington MB; Qian M; Mandlekar S; Christ DD; Trzaskos JM; Newton RC; Magolda RL; Wexler RR; Decicco CP
J Med Chem; 2003 May; 46(10):1811-23. PubMed ID: 12723945
[TBL] [Abstract][Full Text] [Related]
34. N-hydroxyformamide peptidomimetics as TACE/matrix metalloprotease inhibitors: oral activity via P1' isobutyl substitution.
Musso DL; Andersen MW; Andrews RC; Austin R; Beaudet EJ; Becherer JD; Bubacz DG; Bickett DM; Chan JH; Conway JG; Cowan DJ; Gaul MD; Glennon KC; Hedeen KM; Lambert MH; Leesnitzer MA; McDougald DL; Mitchell JL; Moss ML; Rabinowitz MH; Rizzolio MC; Schaller LT; Stanford JB; Tippin T; Warner JR; Whitesell LG; Wiethe RW
Bioorg Med Chem Lett; 2001 Aug; 11(16):2147-51. PubMed ID: 11514157
[TBL] [Abstract][Full Text] [Related]
35. [New fluorescent substrates for metalloendopeptidases with internal quenching of fluorescence].
Filippova IIu; Lysogorskaia EN; Oksenoĭt ES; Troshchenkova EP; Stepanov VM
Bioorg Khim; 1988 Apr; 14(4):467-71. PubMed ID: 3422002
[TBL] [Abstract][Full Text] [Related]
36. Fluorogenic peptide substrates for carboxydipeptidase activity of cathepsin B.
Stachowiak K; Tokmina M; Karpińska A; Sosnowska R; Wiczk W
Acta Biochim Pol; 2004; 51(1):81-92. PubMed ID: 15094828
[TBL] [Abstract][Full Text] [Related]
37. The growth hormone receptor interacts with its sheddase, the tumour necrosis factor-alpha-converting enzyme (TACE).
Schantl JA; Roza M; Van Kerkhof P; Strous GJ
Biochem J; 2004 Jan; 377(Pt 2):379-84. PubMed ID: 14519102
[TBL] [Abstract][Full Text] [Related]
38. Kinetic characterization of lysine-specific metalloendopeptidases from Grifola frondosa and Pleurotus ostreatus fruiting bodies.
Nonaka T; Hashimoto Y; Takio K
J Biochem; 1998 Jul; 124(1):157-62. PubMed ID: 9644258
[TBL] [Abstract][Full Text] [Related]
39. Selective neurotensin-derived internally quenched fluorogenic substrates for neurolysin (EC 3.4.24.16): comparison with thimet oligopeptidase (EC 3.4.24.15) and neprilysin (EC 3.4.24.11).
Oliveira V; Campos M; Hemerly JP; Ferro ES; Camargo AC; Juliano MA; Juliano L
Anal Biochem; 2001 May; 292(2):257-65. PubMed ID: 11355859
[TBL] [Abstract][Full Text] [Related]
40. Measurement of Protease Activities Using Fluorogenic Substrates.
Santamaria S; Nagase H
Methods Mol Biol; 2018; 1731():107-122. PubMed ID: 29318548
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
